Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration of …

Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …

Graves' disease is a common autoimmune disorder in women in fertile ages. The hyperthyroidism
is causedby generation of TSH-receptor activating antibodies. In pregnancy both the …

Background In ESTIMABL1, a randomised phase 3 trial of radioactive iodine ( 131 I)
administration after complete surgical resection in patients with low-risk thyroid cancer, 92% of …

131 I treatment in thyroid cancer patients may induce side effects, including extrathyroidal
cancer and leukemia. There are still some uncertainties concerning parameters that may …

Background/aims The epidemiology of Graves’ orbitopathy (GO) may be changing. The aim
of the study was to identify trends in presentation of GO to tertiary centres and initial …

Context Hyperthyroidism occurs in 1% of neonates born to mothers with active or past
Graves' disease (GD). Current guidelines for the management of GD during pregnancy were …

Background Anaplastic thyroid carcinoma (ATC) is among the most aggressive human
malignancies. It is associated with a high rate of local recurrence and with poor prognosis. …

Purpose In the ESTIMABL phase III trial, the thyroid ablation rate was equivalent for the two
thyroid-stimulating hormone (TSH) stimulation methods (thyroid hormone withdrawal [THW] …

Context: Patients with progressive medullary thyroid carcinoma (MTC) undergo multiple imaging
procedures for diagnosis of relapse and staging. Objective: Our objective was to assess …